ALLIANCE-A032302-ASPIRE
Phase III
OPEN TO ACCRUAL
Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)
IIT-GEORGE-I-PREDICT
Phase I/II
OPEN TO ACCRUAL
An Open-Label, Navigational Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy for Patients with Aggressive Malignancies and Poor Prognoses